24-Mar-2026
PRNewswire (Fri, 20-Mar 10:41 PM ET)
TipRanks (Fri, 20-Mar 8:20 AM ET)
TipRanks (Fri, 20-Mar 8:01 AM ET)
Market Chameleon (Wed, 11-Mar 7:15 AM ET)
3 Reasons Why this HIMS Credit Put Spread Could be a Good Trade at $0.64
Market Chameleon (Wed, 11-Mar 10:18 AM ET)
Hims & Hers Names Kathryn Beiser as Chief Communications Officer
Business Wire (Tue, 10-Mar 8:08 PM ET)
Market Chameleon (Tue, 10-Mar 6:37 AM ET)
Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers
Business Wire (Tue, 10-Mar 9:00 AM ET)
Hims & Hers Announces Strategic Shift for US Weight Loss Business
Business Wire (Mon, 9-Mar 8:30 AM ET)
Business Wire (Mon, 2-Mar 12:00 PM ET)
Hims & Hers Health Inc operates telehealth platforms, providing access to treatments for various chronic conditions, including those related to sexual health, hair loss, hormone health, weight loss, dermatology, and mental health, as well as services such as comprehensive laboratory testing. The company connects patients to licensed healthcare professionals who can prescribe medications, with prescriptions fulfilled online through licensed pharmacies. In addition, it offers access to various non-prescription health and wellness products. Through the Hims & Hers mobile applications, the company also offers access to educational programs, wellness content, community support, and other services that promote lifelong health and wellness. Geographically, it derives maximum revenue from the USA.
Hims & Hers Health Class A trades on the NYSE stock market under the symbol HIMS.
As of March 24, 2026, HIMS stock price declined to $21.34 with 23,587,491 million shares trading.
HIMS has a beta of 1.27, meaning it tends to be more sensitive to market movements. HIMS has a correlation of 0.05 to the broad based SPY ETF.
HIMS has a market cap of $4.86 billion. This is considered a Mid Cap stock.
Last quarter Hims & Hers Health Class A reported $618 million in Revenue and $.08 earnings per share. This fell short of revenue expectation by $-207,922 and exceeded earnings estimates by $.05.
In the last 3 years, HIMS traded as high as $72.98 and as low as $5.65.
The top ETF exchange traded funds that HIMS belongs to (by Net Assets): IJH, IWM, VTI, VB, VBK.
HIMS has underperformed the market in the last year with a price return of -38.6% while the SPY ETF gained +17.1%. HIMS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -38.7% and -3.7%, respectively, while the SPY returned -4.8% and -3.4%, respectively.
HIMS support price is $20.79 and resistance is $24.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HIMS shares will trade within this expected range on the day.